CA2868066C - Method for monitoring hiv specific t cell responses - Google Patents

Method for monitoring hiv specific t cell responses Download PDF

Info

Publication number
CA2868066C
CA2868066C CA2868066A CA2868066A CA2868066C CA 2868066 C CA2868066 C CA 2868066C CA 2868066 A CA2868066 A CA 2868066A CA 2868066 A CA2868066 A CA 2868066A CA 2868066 C CA2868066 C CA 2868066C
Authority
CA
Canada
Prior art keywords
cells
hiv
cytokines
response
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2868066A
Other languages
English (en)
French (fr)
Other versions
CA2868066A1 (en
Inventor
Marta RUIZ RIOL
Christian Brander
Javier IBARRONDO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IrsiCaixa Institut de Recerca de la Sida
Original Assignee
IrsiCaixa Institut de Recerca de la Sida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IrsiCaixa Institut de Recerca de la Sida filed Critical IrsiCaixa Institut de Recerca de la Sida
Publication of CA2868066A1 publication Critical patent/CA2868066A1/en
Application granted granted Critical
Publication of CA2868066C publication Critical patent/CA2868066C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2868066A 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses Active CA2868066C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261615038P 2012-03-23 2012-03-23
EP12382109 2012-03-23
US61/615,038 2012-03-23
EP12382109.2 2012-03-23
PCT/EP2013/056110 WO2013139972A1 (en) 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses

Publications (2)

Publication Number Publication Date
CA2868066A1 CA2868066A1 (en) 2013-09-26
CA2868066C true CA2868066C (en) 2019-11-12

Family

ID=49221879

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2868066A Active CA2868066C (en) 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses

Country Status (9)

Country Link
US (1) US9709577B2 (enExample)
EP (1) EP2828656B1 (enExample)
JP (1) JP6272820B2 (enExample)
CN (1) CN104272108A (enExample)
CA (1) CA2868066C (enExample)
HK (1) HK1205264A1 (enExample)
IN (1) IN2014DN08394A (enExample)
MX (1) MX2014011484A (enExample)
WO (1) WO2013139972A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777256B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 병원체 감염 세포 독성능 평가 방법
KR101777252B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 prrsv 증식 억제능 평가 방법
CN110308285B (zh) * 2019-07-12 2022-07-26 中国人民解放军军事科学院军事医学研究院 用于预测重度电离辐射损伤死亡的标志物组合
AU2023232911A1 (en) * 2022-03-09 2024-10-17 Fundació Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa Boosted immune monitoring methods for assaying antigen-specific t cell responses
CN115754303A (zh) * 2022-11-24 2023-03-07 复旦大学附属华山医院 基于Th1和Th2细胞因子组合的评价方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
CN1230444C (zh) * 1998-11-16 2005-12-07 德克萨斯州立大学董事会 含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
EP1767937A1 (en) * 2005-09-27 2007-03-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method of diagnosis of tuberculosis related immune restoration syndrome (IRS)
AU2007229263B2 (en) * 2006-03-20 2012-08-09 St Vincent's Hospital Sydney Limited A method for detecting antigen-specific or mitogen-activated T cells
WO2008127840A2 (en) * 2007-03-22 2008-10-23 University Of Iowa Research Foundation Flavivirus ns5a proteins for the treatment of hiv
US20090263828A1 (en) * 2008-04-16 2009-10-22 Franco Lori Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
WO2010037408A1 (en) * 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
CN104623666A (zh) * 2011-04-29 2015-05-20 西莱克塔生物科技公司 用于诱导调节性b细胞的致耐受性合成纳米载体

Also Published As

Publication number Publication date
MX2014011484A (es) 2015-09-23
CN104272108A (zh) 2015-01-07
JP2015513100A (ja) 2015-04-30
CA2868066A1 (en) 2013-09-26
US9709577B2 (en) 2017-07-18
IN2014DN08394A (enExample) 2015-05-08
HK1205264A1 (en) 2015-12-11
EP2828656A1 (en) 2015-01-28
US20150057175A1 (en) 2015-02-26
EP2828656B1 (en) 2019-09-18
JP6272820B2 (ja) 2018-01-31
WO2013139972A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
AU2009338127B2 (en) Compositions and methods for assessing cytotoxicity of single cells
US8030005B2 (en) Method for detecting antigen specific or mitogen-activated T cells
Tischer et al. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein–Barr virus-specific T cells as targets of interest in immunotherapeutic approaches
CA2868066C (en) Method for monitoring hiv specific t cell responses
US20160153994A1 (en) Ebv proteins as markers in methods of diagnosing chronic fatigue syndrome (cfs)
Mani et al. Definition and characterization of novel HLA-* A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance
Gärtner et al. Epstein‐Barr Virus
Aguilar-Jimenez et al. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
ES2753249T3 (es) Método para seguir las respuestas de células T específicas al VIH
Burton et al. Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Concomitant assessment of perforin, IFN-γ and IL-4 secretion
US20230349889A1 (en) Methods of Determining Immune Response
US20250180558A1 (en) Boosted immune monitoring methods for assaying antigen-specific t cell responses
US20240180984A1 (en) Methods for determining tumor immune status
Cui et al. Oncogenicity of EBV-infected natural killer T cells deteriorate EBV-related hemophagocytic lymphohistiocytosis
Xu et al. CD38+ HLA-DR+ CD8+ T Cells induced by IL-15 exert liver injury through NKG2D in chronic hepatitis B cirrhosis
Vara Vaccine-and infection-induced cellular immunity against SARS-CoV-2 in humans
Lim et al. Antiviral activity of Cytomegalovirus-specific CD4+ T cells against lytically infected non-haemopoietic cells
CN112710849A (zh) 一种鉴定抗EBV免疫活性的ELISpot试剂盒、制备方法及应用
Lúcia Pérez Assessment of human cytomegalovirus (HCMV)-specific memory T and B cell responses as predictors of HCMV infection after kidney transplantion.
Namasivayam Cytomegalovirus-specific T-cell immunity in paediatric haematopoietic stem cell transplant recipients
Jayasooriya Immune control of epstein-barr virus infection in African children
Thomas Epstein-Barr virus and multiple sclerosis: investigating EBV antigen-induced T-cell cross-recognition of central nervous system proteins
Franzen-Röhl Diagnosis in aseptic meningitis and immune response in herpes simplex virus infections
HK1127120B (en) A method for detecting antigen-specific or mitogen-activated t cells

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180322